First interview of Hiral Chandrana

#MASTEK

Adding 40+ customers every quarter from an year
650+ active clients

Met 150+ customers/partners virtually in last 40days

Focus to accelerate US growth-have strategy in place

960cr cash on books
Looking for organic+inorganic growth

More from Shreenidhi P

Cosmo films
Investor ppt

Splty side:3yr target
Masterbatches-10% rev,20% RoCE
Textile chem-10% rev,25% RoCE
FMCG-Fabricizer launched

30% RoE,22% RoCE-fy21

1% shift in splty adds 5cr EBITDA
Target-62% to 80%

Net d/e 0.5x
D/EBITDA 1x

Petcare-plans 2 demerge in2 seperate entity https://t.co/Iq4VT6tG50

More from Mastek

You May Also Like

@EricTopol @NBA @StephenKissler @yhgrad B.1.1.7 reveals clearly that SARS-CoV-2 is reverting to its original pre-outbreak condition, i.e. adapted to transgenic hACE2 mice (either Baric's BALB/c ones or others used at WIV labs during chimeric bat coronavirus experiments aimed at developing a pan betacoronavirus vaccine)

@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice


@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2


@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj


@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o